Genomics
The HiSeq 2500 and 4000 Systems are the most effective instruments for next-generation sequencing.
Manufacturer: Illumina, USA.
Web site: http://www.illumina.com/systems/hiseq_2500_1500.html.
The HiSeq 2500 and 4000 Systems are the most effective instruments for next-generation sequencing.
Manufacturer: Illumina, USA.
Web site: http://www.illumina.com/systems/hiseq-3000-4000.html.
The MiSeq personal sequencing system enables researchers to go from sample to analyzed data in as little as eight hours with a revolutionary workflow and unmatched accuracy. Capable of generating up to 7.0 Gb per run, MiSeq is the only next-generation sequencer that integrates amplification, sequencing, and data analysis in a single instrument.
Manufacturer: Illumina, USA.
Web site: http://www.illumina.com/systems/miseq.html.
The QIAsymphony SP enables automatic sample preparation of DNA and RNA from 1-96 samples at once in batches of 24. It allows safe and contamination-free processing of a wide range of starting materials and sample volumes using dedicated kits. Among the most requested sample types are the whole fresh or frozen blood and buffy coat. Among the other possible sample types are FFPE and fresh tissues. The system is optimized to extract ultrapure RNA from the gold standard PAXgene RNA tubes. It is ideal for projects that require large amounts of consistently high quality DNA samples for downstream applications as qPCR, Next Generation Sequencing and genotyping.
Manufacturer: QIAGEN, Germany.
Catalog number: 9001297.
ProFlex™ PCR System is an end-point thermal cycler, specifically designed for the amplification of nucleic acids using the Polymerase Chain Reaction (PCR) process. This system allows running 3 fully independent reaction setups. The user interface consists of a touchscreen with a graphical display that shows the time, status, and temperature for each run. A touchscreen keypad allows you to into information into fields on the display screen.
Manufacturer: Applied Biosystems, USA.
Catalog number: 4484073.
